Martina Flammer M.D. sold $771k of INSM
Chief Medical Officer at INSMED Inc. 11,724 shares at an average of $65.79, traded May 15, 2025, filed May 19, 2025.
Score components
- +15RoleOfficer
- +22Trade size$771k at market
- +5Share of holdings soldSold 12% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +46.5%, 3m +87.5%, 6m +190.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-026581, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 15, 2025 | AGrant or award Common Stock10b5-1 | +6,508 | $0.00 | $0 | 96,521 | May 19, 2025 |
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -9,925 | $65.47 | $650k | 86,596 | May 19, 2025 |
| May 16, 2025 | SOpen-market sale Common Stock10b5-1 | -1,799 | $67.53 | $121k | 84,797 | May 19, 2025 |
| May 15, 2025 | AGrant or award Stock Option (right to buy)derivative10b5-1 | +31,610 | $0.00 | $0 | 31,610 | May 19, 2025 |
Related signals
Other insiders at INSMED Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | INSMsell INSMED Inc | David R Brennan director | $3.1M 25,000 shares | -39% | |
| 23Weak | INSMED Inc | William Lewis Chair and CEO | $2.2M 21,398 shares | -8% | |
| 14Weak | INSMED Inc | Michael Alexander Smith Chief Legal Officer | $173k 1,806 shares | -5% | |
| 40Moderate | INSMED Inc | William Lewis Chair and CEO | $613k 6,515 shares | -2% | |
| 48Moderate | INSMED Inc | Roger Adsett Chief Operating Officer | $242k 2,370 shares | -2% | |
| 50Moderate | INSMED Inc | Sara Bonstein Chief Financial Officer | $246k 2,404 shares | -3% | |
| 27Weak | INSMED Inc | Martina Flammer M.D. Chief Medical Officer | $455k 4,424 shares | -7% | |
| 62Notable | INSMED Inc | William Lewis Chair and CEO | $778k 7,605 shares | -3% | |
| 42Moderate | INSMED Inc | Michael Alexander Smith Chief Legal Officer | $221k 2,159 shares | -5% | |
| 35Weak | INSMED Inc | Michael Alexander Smith Chief Legal Officer | $667k 6,149 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.